Letter to the editor regarding ‘Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY‑2 clinical trial subanalysis’

• Cem Onal ^[1] ; Ezgi Oymak ^[2]
  1. [1] Department of Radiation Oncology, Adana Dr. Turgut Noyan Research and Treatment Center, Baskent University Faculty of Medicine, 01120, Adana, Turkey Department of Radiation Oncology, Baskent University Faculty of Medicine, Ankara, Turkey
  2. [2] Division of Radiation Oncology, Iskenderun Gelisim Hospital, Hatay, Turkey
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 24, Nº. 6 (junio), 2022, págs. 1215-1216
• Idioma: inglés
• Enlaces
  • Texto completo (pdf)